[CABS] Contact Tracing and Control of COVID-19 Community Spread


The COVID‑19 pandemic, is an ongoing global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). As of August 10th, 2020, approximately 20.1 million confirmed COVID-19 cases, and more than seven hundred thousand deaths had been attributed to COVID-19 worldwide.

The COVID-19 pandemic has caused global social and economic disruption, including the largest global recession since the Great Depression. As the world reopens, we continue to face challenges in controlling the community spread of coronavirus. What are the current status and further trends? Comparison of the COVID-19 situation in Massachusetts (East Coast) and California (West Coast)? How do some heavily-populated countries like India and Brazil fight the disease? How to control coronavirus community spread? How should we do contact tracing? What’s the current progress in medical therapeutics and vaccine development? What hi-tech innovative solution can help to fight this war?

Please join us in the upcoming webinar “Contact Tracing and Control of COVID-19 Community Spread” on Saturday, August 22nd, 2020, 2:00 – 4:30 PM PST. CABS has partnered with Gracious Life Foundation (GLF), Chinese American Semiconductor Professional Association (CASPA), to organize this exciting event. We have invited a panel of distinguished speakers from public health, clinical medicine, and big data analytics.

新冠(COVID‑19)疫情是由严重的急性呼吸综合征冠状病毒(SARS‑CoV‑2)引起的持续的全球疫情。 截至2020年8月10日,全球约有2010万例确诊的新冠病例,其中有70多万人不幸死于新冠。

新冠疫情已造成全球规模的社会和经济混乱,是自大萧条以来最大的全球衰退。 随着世界的重新开放,我们在控制冠状病毒的社区传播方面持续面临着挑战。 新冠疫情目前的状况和将来的趋势如何?马萨诸塞州(东海岸)和加利福尼亚州(西海岸)的新冠疫情有何不同? 一些人口稠密的国家(如印度和巴西)是如何抵抗新冠疫情? 如何能有效的控制冠状病毒的社区传播? 我们应该如何进行新冠患者接触者的跟踪? 在医学治疗和疫苗开发方面有什么最近进展? 目前有什么高科技创新的解决方案可以帮助抵抗这场新冠战争?

请与我们一起参加即将于太平洋标准时间2020年8月22日(星期六)举行的“ 新冠患者接触者的追踪和新冠病毒社区传播的控制”网络研讨会。 北美华人生物医药协会(CABS)与华美半导体协会(CASPA), 慈善生命基金会(GLF)合作组织了这次激动人心的活动。 我们邀请了来自公共卫生,临床医学和算法和数据分析的杰出讲员来分享最新的前沿进展。讲员阵容强大:有柏克利加大公卫学院院长详述该校抗役九大创新;洛杉矶加大公卫学院付院长宏观视野比较分析欧美、印度、巴西、东西岸两州疫情;资深医生展望新冠药物及新冠疫苗前景;还有关心奥数竞赛的学子和虎妈所熟悉和崇拜的,带领美国奥林匹克数学竞赛队赢得四次冠军的总教练,卡内基梅隆大学数学教授 ——罗博深讲解和演示基于数论灵感和超声波技术开发的,既注重用户隐私,又能及时进行疫情信息通知的软件—— NOVID.

Agenda (August 22, 2020, Saturday; Agenda is based on US Pacific Time)

2:00 pm – 2:10 pm    Introduction to CABS, Yang Tian, President of CABS

Introduction to CASPA, Song Xue, President of CASPA

Introduction to GLF, Weixing Chen, President of Gracious Life Foundation

2:10 pm – 2:40 pm    Innovating Solutions to Covid-19, Michael C. Lu, MD, MS, MPH, University of California, Berkeley

2:40 pm – 3:10 pm    Progress in COVID-19 Therapeutic/Vaccine Research, James Mu, MD, PERMC and WWMG, Seattle, WA

3:10 pm – 3:40 pm    Epidemiology and Control of COVID-19 Pandemics: Current Status & Future Trends, Zuo-Feng Zhang, MD, PhD, University of California, Los Angeles

3:40 pm – 4:05 pm    An alternative paradigm for app-based contact tracing which incentivises adoption, Po-shen Loh, PhD, Professor, Carnegie Melon University

4:05 pm – 4:30 pm    Panel Discussion moderated by Michael Prelip, PhD, Professor and Chair, Department of Community Health Sciences, University of California, Los Angeles


Michael C. Lu, MD, MS, MPH

Dean, School of Public Health, University of California, Berkeley

Dr. Michael C. Lu is formerly a bureau director for maternal and child health in the Obama Administration and also professor of ob-gyn and public health at UCLA. He is the current Dean of the UC Berkeley School of Public Health, has a deep-rooted passion for health equity and social justice. He has dedicated his research to the development, testing and translation of a new theory on the origins of maternal and child health disparities.

James Mu, MD.

PERMC and WWMG, Seattle, WA

Dr. James Mu is a practicing physician in the Seattle area. He received his undergraduate medical education and his first medical residency and GI fellowship in Chengdu, China. In the US, he did internal medicine residency and GI fellowship at Washington University in St. Louis. He also completed research GI fellowship at Washington University. As a postdoctoral research fellow, he received ” individual National Research Service Award (NRSA)” from NIH and “Young Investigator’s Award” from Federation of American Societies for Experimental Biology (FASEB). In 2000 he joined Western Washington Medical Group and Providence Regional Medical Center in the Seattle area. He has been rated as a Top Doctor multiple times since 2009 by Seattle Metropolitan magazine and by Seattle Magazine.

Zuo-Feng Zhang, MD, PhD.

Distinguished Professor of Epidemiology, Associate Dean for Research Fielding School of Public Health, University of California, Los Angeles

Dr. Zuo-Feng Zhang is a Distinguished Professor of Epidemiology and Associate Dean for Research of the UCLA Fielding School of Public Health. He is also Co-Director of the UCLA Alper Center for Environment Genomics, and Director of Cancer Molecular Epidemiology Training Program. Dr. Zhang had been a Fellow of the American College of Epidemiology (ACE). He served a member of the Board of Directors of the American College of Epidemiology and a World Health Organization (WHO) Consultant for National Non-communicable Disease Prevention and Controls in China.

Po-shen Loh, PhD.

Professor, Department of Mathematics, Carnegie Melon University

Professor Po-shen Loh is a social entrepreneur, working across the spectrum of mathematics: from education to pure and applied research. He is a math professor at Carnegie Mellon University, and the founder of the free personalized learning platform expii.com, a social enterprise supported by his own Daily Challenge series of online middle school math courses that reinvent middle school math for students seeking more than the standard USA curriculum. He is also the national coach of the USA International Mathematical Olympiad team which ranked #1 in the world 4 times in the last 5 years. During the COVID-19 outbreak, he turned his mathematical attention to creating NOVID, the world’s first (and still only) COVID-19 app demonstrably capable of measuring distance with the requisite accuracy for contact tracing.He has been recognized by various awards, from an International Math Olympiad silver medal to the USA Presidential Early Career Award for Scientists and Engineers.

Michael Prelip, DPA.

Professor and Chair, Department of Community Health Sciences, University of California, Los Angeles

Dr. Mike Prelip is currently a professor and chair of the Department of Community Health Sciences (CHS) at the University of California Los Angeles (UCLA) Fielding School of Public Health. He was also the School’s first Associate Dean of Practice and for many years the director of the CHS MPH for Health Professionals Program. He is currently involved in a number of translational research projects, which are all community based and public health focused, using a community engagement model. Dr. Prelip conducts his work in both domestic and international settings. He has received numerous prestigious National Institute of Health awards to support his research, including multiple awards from the National Institute of Child Health and Human Development, the National Heart Lung Blood Institute, the National Institute of Nursing Research and the Fogarty Center. He also directs a number of NIH and CDC funded training programs focusing on health disparities. Recently he was awarded a $2.7 million grant from the CDC to establish FSPH’s Undergraduate Public Health Scholars Program. In response to the COVID-19 pandemic, Dr. Prelip is co-leading UCLA’s partnership with UC San Francisco to train over 10,000 COVID-19 contact tracers and case investigators for the California Department of Public Health being deployed throughout California. He is also working with the Andean Parliament (consortium of Bolivia, Peru, Colombia, Ecuador, and Chile) to create similar trainings for these South American countries.